SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-066456
Filing Date
2023-08-14
Accepted
2023-08-14 07:00:28
Documents
15
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183398-8k_intensity.htm   iXBRL 8-K 32514
2 PRESS RELEASE ISSUED AUGUST 14, 2023 ea183398ex99-1_intensity.htm EX-99.1 73157
7 GRAPHIC ex99-1_001.jpg GRAPHIC 14324
  Complete submission text file 0001213900-23-066456.txt   355709

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ints-20230814.xsd EX-101.SCH 3299
4 XBRL DEFINITION FILE ints-20230814_def.xml EX-101.DEF 26216
5 XBRL LABEL FILE ints-20230814_lab.xml EX-101.LAB 35952
6 XBRL PRESENTATION FILE ints-20230814_pre.xml EX-101.PRE 24874
9 EXTRACTED XBRL INSTANCE DOCUMENT ea183398-8k_intensity_htm.xml XML 4659
Mailing Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880
Business Address 61 WILTON ROAD, 3RD FLOOR WESTPORT CT 06880 203-221-7381
INTENSITY THERAPEUTICS, INC. (Filer) CIK: 0001567264 (see all company filings)

IRS No.: 461488089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41109 | Film No.: 231166161
SIC: 2836 Biological Products, (No Diagnostic Substances)